27 September, 2014 by The TZ Newswire Staff Comments Off on Can Cadillac’s New Leader Fix the Brand?
Can Cadillac’s New Leader Fix the Brand?
Johan de Nysschen was brought in from Nissan to help fix the glut of problems weighing Cadillac down. What can he do to help the automaker succeed again?
27 September, 2014 by The TZ Newswire Staff Comments Off on Syria, Neo-Cons, And The Attempted Infiltration Of The Liberty Movement
Syria, Neo-Cons, And The Attempted Infiltration Of The Liberty Movement
Submitted by Brandon Smith of Alt-Market.com,
27 September, 2014 by The TZ Newswire Staff Comments Off on The Wall Street Journal: India’s Modi wants new talks with Pakistan
The Wall Street Journal: India’s Modi wants new talks with Pakistan
Indian Prime Minister Narendra Modi says his government is seeking serious bilateral talks with Pakistan but can’t engage in talks under “a shadow of terrorism.”
read more
27 September, 2014 by The TZ Newswire Staff Comments Off on NYC soccer team struggles to find a place to play
NYC soccer team struggles to find a place to play
New York City Football Club’s search for a stadium may be the only game with an ending less satisfying than a shoot-out.
27 September, 2014 by The TZ Newswire Staff Comments Off on Is ISIS Using Alibaba To Buy Mobile Refineries From Turkey?
Is ISIS Using Alibaba To Buy Mobile Refineries From Turkey?
It all started with a Pentagon tweet showing a before and after picture of a “modular oil refinery” used by ISIS:
.@PentagonPresSec re #Syria: Before & after photos of #Jeribe modular oil refinery — targets of coalition attacks. pic.twitter.com/pfpSJhxPwa
27 September, 2014 by The TZ Newswire Staff Comments Off on Tough luck, NSA: New iPhone locks out spy agency
Tough luck, NSA: New iPhone locks out spy agency
The new, post-Edward Snowden smartphone is the first that will disrupt American spying, the New York Times reports.
27 September, 2014 by The TZ Newswire Staff Comments Off on 1 Marijuana Stock You Can Buy Right Now
1 Marijuana Stock You Can Buy Right Now
While many medical marijuana stocks are trading at jaw-dropping valuations, Insys may be a relative value given the potential approval of its synthetic THC drug, dronabinol.